Immunoprophylaxis of leprosy: Current status and future prospects

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 2, 2007, Pages 71-72

  Sehgal, V N ^a   Sardana, K ^b  

^a Sehgal Nursing Home   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; PLACEBO;

BCG VACCINATION; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HUMAN; IMMUNOPROPHYLAXIS; MULTIBACILLARY LEPROSY; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM WELCHII; PAUCIBACILLARY LEPROSY; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 34247553826     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.31888     Document Type: Editorial

References (17)

1. Sehgal VN, Sardana K. Lepra vaccine: Misinterpreted myth. Int J Dermatol 2006;45:164-7.
2. Sehgal VN, Sardana K. Lepra vaccine. Skin Med 2004;3:167-8.
3. Britton WJ, Lockwood DN. Leprosy. Lancet 2004;363:1209-19.
4. Smith WC. What is the best way to use BCG to protect against leprosy: When, for whom and how often? Int J Lepr Other Mycobact Dis 2004;72:48-9.
5. Convit J, Ulrich M. Immunotherapy and Immunoprophylaxis of leprosy. Indian J Lepr 2000;72:21-32.
6. Anonymous. World Health Organization. Leprosy. 2005
7. Setia MS, Steinmaus C, Ho CS, Rutherford GW. The role of BCG in prevention of leprosy: A meta-analysis. Lancet Infect Dis 2006;6:162-70.
8. Bottasso O, Merlin V, Cannon L, Cannon H, Ingledew N, Keni M, et al. Studies of vaccination of persons in close contact with leprosy patients in Argentina. Vaccine 1998;16:1166-71.
9. Ganapati R, Revankar CR, Lockwood DN, Wilson RC, Price JE, Ashton P, et al. A pilot study of three potential vaccines for leprosy in Bombay. Int J Lepr Other Mycobact Dis 1989;57:33-7.
10. Gormus BJ, Baskin GB, Xu K, Marion S, Ratterree MS, Martin LN, et al. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: Immunologic observations. Int J Lepr Other Mycobact Dis 2000;68:27-39.
11. Shepard CC. Vaccination against human leprosy bacillus infections of mice: Protection by BCG given during the incubation period. J Immunol 1966;96:279-83.
12. Ponnighaus JM, Fine PE, Sterne JA, Wilson RJ, Msosa E, Gruer PJ, et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992;339:636-9
13. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
14. Zodpey SP. Protective Effect of bacillus Calmette Guerin (BCG) Vaccine in Prevention of Leprosy: A Meta-Analysis. 2007;73:86-93.
15. Gupte MD. South India immunoprophylaxis trial against leprosy: Relevance of findings in the context of leprosy trends. Int J Lepr Other Mycobact Dis 2001;69:S10-3.
16. Bhattacharya SN, Sehgal VN. Reappraisal of the drifting scenario of leprosy multi-drug therapy: New approach proposed for the new millennium. Int J Dermatol 2002;41:321-6.
17. Sharma P, Mukherjee R, Talwar GP, Sarathchandra KG, Walia R, Parida SK, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: Clinical field trials with a follow up of 8-10 years. Lepr Rev 2005;76:127-43.